Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

Overview of attention for article published in Frontiers in Molecular Biosciences, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 2 blogs
twitter: 1 X user

patent: 4 patents

Readers on

mendeley: 169 Mendeley

So far, Altmetric has seen 2 posts from 2 blogs.

A computational study of metal–organic frameworks (MOFs) as potential nanostructures to combat SARS-CoV-2

Computational Chemistry Daily, 21 Sep 2022

nature.com - The COVID-19 causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a critical surface…

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19.

Clinowl, 21 Dec 2020

The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) rapidly turned into an unprecedented pandemic…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.